| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0008 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.002 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |